History
  • No items yet
midpage
in Re Caraco Pharmaceutical Laboratories Shareholder Litigation
329933
| Mich. Ct. App. | Jun 13, 2017
Read the full case

Background

  • Caraco Pharmaceutical Laboratories, Ltd. was a Detroit-based generic drug manufacturer.
  • Sun Pharmaceutical and Sun Global owned about 75.8% of Caraco; Shanghvi controlled Sun and Caraco.
  • GPT: Sun proposed to acquire remaining Caraco shares and take it private; an Independent Committee reviewed the offer.
  • An amended complaint added claims about a scheme to depress Caraco’s value prior to the GPT and alleged mis/disclosures.
  • Trial court granted summary disposition under MCR 2.116(C)(8); appellate remand allowed amendment and further proceedings.
  • Court reverses and remands for further proceedings consistent with its opinion.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Law-of-the-case applicability to Counts II–V Law of the case did not bind on remand Law-of-the-case bound trial court, precluding new findings Law-of-the-case does not apply to Counts II–V; reversal warranted
Exculpatory clause and fiduciary liability Exculpation does not bar claims for intentional harm Exculpation precludes fiduciary-duty claims Exculpatory clause does not bar claims for intentional harm or scheme to depress value
Bell–Blair communications and fiduciary duty Allegations show breach via Bell with Blair Record insufficient to prove breach under pleadings Amended complaint states breach of fiduciary duty related to Bell–Blair communications
Bell–Shanghvi scheme to depress stock Alleged plan to depress price violated duties No pleading supports plan Amended complaint states breach of fiduciary duty by Bell and Shanghvi
Business judgment rule applicability Rule cannot shield fraudulent/bad-faith conduct Rule forecloses challenge to GPT Business judgment rule does not defeat fiduciary-duty claims given alleged fraud/bad faith

Key Cases Cited

  • Maiden v Rozwood, 461 Mich 109 (Mich 1999) (de novo review of summary disposition; if genuine issue remains, reversal allowed)
  • Churella v Pioneer State Mut Ins Co (On Remand), 258 Mich App 260 (Mich App 2003) (business judgment rule limits, not absolutely bars, review of director decisions)
  • Webb v Smith (After Second Remand), 224 Mich App 203 (Mich App 1997) (law-of-the-case scope and application)
Read the full case

Case Details

Case Name: in Re Caraco Pharmaceutical Laboratories Shareholder Litigation
Court Name: Michigan Court of Appeals
Date Published: Jun 13, 2017
Docket Number: 329933
Court Abbreviation: Mich. Ct. App.